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Background
The COVID-19 pandemic and mitigation measures are likely to
have a marked effect on mental health. It is important to use
longitudinal data to improve inferences.
Aims
To quantify the prevalence of depression, anxiety and mental
well-being before and during the COVID-19 pandemic. Also, to
identify groups at risk of depression and/or anxiety during the
pandemic.
Method
Data were from the Avon Longitudinal Study of Parents and
Children (ALSPAC) index generation (n = 2850, mean age 28
years) and parent generation (n = 3720, mean age 59 years), and
Generation Scotland (n = 4233, mean age 59 years). Depression
was measured with the Short Mood and Feelings Questionnaire
in ALSPAC and the Patient Health Questionnaire-9 in Generation
Scotland. Anxiety andmental well-beingweremeasuredwith the
Generalised Anxiety Disorder Assessment-7 and the Short
Warwick Edinburgh Mental Wellbeing Scale.
Results
Depression during the pandemic was similar to pre-pandemic
levels in the ALSPAC index generation, but those experiencing
anxiety had almost doubled, at 24% (95% CI 23–26%) compared
with a pre-pandemic level of 13% (95% CI 12–14%). In both
studies, anxiety and depression during the pandemic was
greater in younger members, women, those with pre-existing
mental/physical health conditions and individuals in socio-
economic adversity, even when controlling for pre-pandemic
anxiety and depression.
Conclusions
These results provide evidence for increased anxiety in young
people that is coincident with the pandemic. Specific groups are
at elevated risk of depression and anxiety during the COVID-19
pandemic. This is important for planning current mental health
provisions and for long-term impact beyond this pandemic.
Keywords
COVID-19; ALSPAC; generation Scotland; anxiety disorders;
depressive disorders.
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Background
The COVID-19 pandemic has resulted in radical changes to soci-
eties globally. As the number of infected cases and deaths increased,
many countries adopted public health measures, including lock-
down, social distancing, self-isolation and school and business clo-
sures, resulting in an unprecedented impact on the global economy,
which may also have a profound effect on mental health.1–3
However, the extent to which mental health is affected by
COVID-19 and its management, and who is at greatest risk, is
still unclear. Evidence from previous outbreaks such as the severe
acute respiratory syndrome epidemic,4–8 and rapid COVID-19
cross-sectional surveys, suggest that depression, anxiety and lower
well-being may increase during the COVID-19 pandemic.9–12
Several rapid cross-sectional surveys during the pandemic have
suggested a higher prevalence of anxiety, depression9,10 and low
well-being compared with historical estimates.12 However, these
studies lack pre-pandemic information on mental health assess-
ments, and potential confounding factors, in the same people
before the pandemic. This precludes accurate assessment of
whether adverse mental health outcomes during the pandemic are
largely accounted for by those with existing or previous mental
health problems having poorer mental health as a result of
COVID-19 mitigation efforts, or whether there are important con-
tributions of the pandemic that are related to poor mental health in
those with no previous history. Furthermore, selection bias (because
of mental health influencing those who respond to surveys) and
reporting bias (from those who perceive depression and anxiety as
higher or are more likely to report symptoms when they feel there
is a ‘valid’ reason) could threaten the validity of results from
cross-sectional surveys. There is a need for longitudinal designs
with well-characterised sampling frames and pre-pandemic
data.13 Such studies can more accurately quantify differences in
mental health from pre-pandemic levels, and identify groups that
are most at risk of adverse mental health in response to the
COVID-19 pandemic. These results can then inform development
of interventions for those at heightened risk, and aid policy deci-
sions regarding the immediate and subsequent management of
the COVID-19 response. This includes plans for easing restrictions
and monitoring at-risk groups as subsequent waves or epidemics
occur, and plans for the longer-term care for groups whose
mental health may be particularly affected.1,14 The COVID-19 pan-
demic is likely to exacerbate existing social and psychological
inequalities.15 Previous studies have identified several groups who* These authors contributed equally to this work.
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may be at greater risk of poorer mental health during the pandemic,
including younger people, parents, women, healthcare workers and
those with poorer financial or living circumstances.9–11,16 However,
many groups remain unexplored, such as individuals at risk of abuse
and those at greater physical risk of COVID-19 (older age, and those
with chronic conditions such as asthma or obesity).
Aims
We aimed to use data from two independent longitudinal cohort
studies, both with rich pre-pandemic measures of mental health,
to quantify how mental health changed from pre-pandemic levels
to the COVID-19 pandemic, and identify groups within the popu-
lation at greater risk of poorer mental health during the pandemic.
The first of these is important for exploring the impact of COVID-
19 and its management on mental health and potential increases in
poor mental health long term. The second is important for targeting
of mental healthcare needs now, and during any subsequent waves,
and for identifying groups who might benefit from long-term mon-
itoring after the pandemic.
Method
Samples
We selected two comparable cohort studies, to allow replication in
different regions of the UK, both with similar timings of mental
health measures before and during the COVID-19 pandemic.
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is an ongoing longitudinal population-based study
that recruited pregnant women residing in Avon (South-West
England) with expected delivery dates between 1 April 1991 and
31 December 1992.17,18 The cohort comprised 13 761 mothers
and their partners (hereafter referred to as ALSPAC-parents), and
their 14 901 children, now young adults (hereafter referred to as
ALSPAC-young).19 The study website contains details of all data,
available through a fully searchable data dictionary (http://www.
bristol.ac.uk/alspac/researchers/our-data/). Ethical approval for
the study was obtained from the ALSPAC Ethics and Law
Committee and the Local Research Ethics Committees.
Generation Scotland: Scottish Family Health Study is a family
longitudinal study of 24 084 individuals recruited across Scotland
between 2006 and 2011.20 Participants were recruited into the
study if they were aged ≥18 years. Participants of Generation
Scotland have been followed up longitudinally,21 and further
details can be found on the study website (http://www.generation
scotland.org). Ethical approval for the study was approved by
National Health Service Tayside Committee on Medical Research
Ethics (reference 05/S1401/89). We assert that all procedures
contributing to this work comply with the ethical standards of the
relevant national and institutional committees on human experi-
mentation and with the Helsinki Declaration of 1975, as revised
in 2008. Written informed consent was obtained from all partici-
pants in both studies.
This study uses data from 3720 individuals in the ALSPAC-
parents cohort and 2973 individuals in the ALSPAC-young
cohort who completed an online questionnaire about the impact
and consequences of the COVID-19 pandemic between 9 April
and 14 May 2020 (see Supplementary Figs 1 and 2 available at
https://doi.org/10.1192/bjp.2020.242).22 In Generation Scotland,
data were from 4233 individuals who completed a similar online
COVID-19 questionnaire between 17 April and 17 May 2020 (see
Supplementary Fig. 3). Mitigation measures were announced in
the UK on the 24 March 2020.
COVID-19 pandemic measures of mental health
The measures used here examine symptoms in the preceding 2
weeks, and thus represent mental health in the immediate period
following mitigation. Depressive symptoms in ALSPAC were mea-
sured with the Short Mood and Feelings Questionnaire (SMFQ),23 a
13-item instrument with scores ranging between 0 and 26, with
higher scores indicting higher depressive symptoms. In
Generation Scotland, depressive symptoms were measured with
the Patient Health Questionnaire-9 (PHQ-9),24 a nine-item instru-
ment with scores ranging between 0 and 27, with higher scores indi-
cating worse depressive symptoms. Anxiety symptoms in ALSPAC
and Generation Scotland were both measured with the Generalised
Anxiety Disorder Assessment-7 (GAD-7),25 a seven-item instru-
ment with ranging between 0 and 21, with higher scores indicting
greater generalised anxiety disorder symptoms. Mental well-being
in ALSPAC and Generation Scotland were both measured with the
Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS),26
a seven-item instrument with scores ranging between 7 and 35, with
higher scores indicating better mental well-being. These measures
have recommended cut-offs for examining the proportion of indivi-
duals with probable depression (≥11 on the SMFQ and ≥10 on the
PHQ-9),24,27 generalised anxiety disorder (≥10 on the GAD-7)28
and poor mental well-being (≤17 on the SWEMWBS),29 with good
sensitivity and specificity for identifying clinical disorder, using vali-
dated interviews and instruments, and are widely used in primary
care and clinical trials. Herein, we refer to depressive symptoms as
depression, and anxiety symptoms as anxiety.
Pre-pandemic assessments ofmental health and factors
Pre-pandemic depression and anxiety were assessed in ALSPAC
and Generation Scotland before the COVID-19 pandemic. In the
ALSPAC-young cohort, pre-pandemic mental well-being was also
assessed. The median length of time between the pre-pandemic
assessments and COVID-19 pandemic assessments of mental
health ranged from 2 to 7 years in the ALSPAC-young cohort, 7
to 20 years in the ALSPAC-parents cohort and 4 to 5 years in the
Generation Scotland cohort. These measures, their timings and har-
monisation are described in Table 1 and in Supplementary
Methods, alongside detailed information on pre-pandemic factors
that may be associated with poorer mental health during the
COVID-19 pandemic in regression analyses. We refer to these as
factors to make it clear that we are not assuming they are causal,
but could be useful in the short term, for identifying at-risk
groups. Factors included sociodemographic information, such as
biological sex, age, educational background, financial circum-
stances, deprivation status, victimisation and being a parent with
school-aged children. Additional factors included pre-existing
mental health conditions, substance misuse, genetic risk for depres-
sion, cognitive styles, personality traits and difficulties accessing
mental health information. Because of differences in data collection,
several factors are only assessed in either ALSPAC or Generation
Scotland. We also examined associations with several COVID-19-
specific factors, including pre-pandemic obesity, pre-pandemic
asthma, a self-reported suspected or confirmed diagnosis of
COVID-19, isolation status, living alone, access to a garden and
healthcare worker and key worker status.
Statistical analysis
Analysis was conducted in StataSE, version 15 for Windows
(StataCorp LLC). Initially, we described the prevalence of mental
health outcomes during the COVID-19 pandemic in all cohorts.
To answer our first research objective (How has the prevalence of
mental health changed from pre-pandemic to COVID-19?), we
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used the ALSPAC-young cohort to quantify differences in mental
health from pre-pandemic to COVID-19 levels, as this was the
only cohort with the identical measures of mental health assessed
before and during the pandemic (i.e., the SMFQ, GAD-7 and
SWEMWBS). Our hypothesis is that the COVID-19 pandemic is
likely to have caused a rise in depression and anxiety in the popula-
tion as a whole. This hypothesis cannot be explicitly tested, given
that COVID-19 mitigation efforts have been a universal exposure.
However, looking at changes from baseline analysis provides
some initial evidence for this hypothesis. The GAD-7 was only
assessed once before the pandemic (between 2014 and 2015), so
we also compared the prevalence of anxiety during the COVID-
19 pandemic with probable anxiety disorder as assessed with the
Clinical Interview Schedule – Revised,33 at two other occasions
(between 2008 and 2010 and between 2015 and 2017). This was
to provide more thorough pre-pandemic information on anxiety,
and to harmonise timings for pre-pandemic mental health. We
also analysed item-level responses for the SMFQ, GAD-7 and
SWEMWBS to examine how specific mental health items differed
before and during the pandemic.
Table 1. Pre-pandemic mental health measures and factors assessed in ALSPAC and Generation Scotland
ALSPAC-parents ALSPAC-young Generation Scotland
Sociodemographic factors
Sex Questionnaire; 1991–1992 Questionnaire item; 1991–1992 Questionnaire; 2006–2011
Age Questionnaire; 2020 Questionnaire; 2020 Questionnaire; 2020
Educational background Questionnaire; 1991–1992 Questionnaire; 1991–1992 Questionnaire; 2006–2011
Income Questionnaire; 2011–2014 Questionnaire; 2017–2018 Questionnaire; 2006–2011
Deprivation status Indices of multiple deprivation; 2014 Indices of multiple deprivation; 2014 Indices of multiple deprivation;
2006–2011
Recent financial problems Questionnaire; 2010–2013 Questionnaire; 2018–2020 Questionnaire; 2015–2016
Partner emotional abuse Life Events Questionnaire; 2010–
2013
Not assessed Not assessed
Parent with young children Not assessed Questionnaire; 2012–2020 Questionnaire; 2020
Physical health factors
Obesity BMI > 30 kg/m2, assessed at a
research clinic; 2011–2015
BMI > 30 kg/m2, assessed at a research
clinic; 2015–2017
BMI > 30 kg/m2, assessed at a research
clinic; 2006–2011
Asthma Questionnaire; 2002–2004 Questionnaire; 2014–2015 Questionnaire; 2006–2011
COVID-19-specific factors
Infection status Questionnaire; 2020 Questionnaire; 2020 Questionnaire; 2020
Isolation status Questionnaire; 2020 Questionnaire; 2020 Not assessed
Living alone Questionnaire; 2020 Questionnaire; 2020 Questionnaire; 2020
No access to a garden Questionnaire; 2020 Questionnaire; 2020 Questionnaire; 2020
Healthcare worker Questionnaire; 2020 Questionnaire; 2020 Not assessed
Key worker Questionnaire; 2020 Questionnaire; 2020 Questionnaire; 2020
Pre-pandemic mental health measures
Depressive symptoms Edinburgh Postnatal Depression
Scale30; 2011–2013
Short Mood and Feelings Questionnaire23;
2017–2018
General Health Questionnaire –
Depression31; 2015–2016




General Health Questionnaire –
Anxiety31; 2015–2016
Mental well-being Not assessed Short Warwick-Edinburgh Mental Wellbeing
Scale26; 2015–2016
Not assessed
Psychiatric or mental health factors
Probable major depression Life Events Questionnaire; 2001–
2003
Clinical Interview Schedule – Revised33;
2015–2017




Life Events Questionnaire; 2003–
2005
Clinical Interview Schedule – Revised33;
2015–2017
Not assessed




Disordered eating Life Events Questionnaire; 2001–
2003





Not assessed Obsessive–Compulsive Inventory37; 2016–
2017
Not assessed
Autistic traits Not assessed Social Responsiveness Scale38; 2016–2017 Not assessed
Personality disorder traits Karolinska Scales of Personality39;
2000–2002
Standardised Assessment of Personality:
Abbreviated Scale40; 2015–2017
Not assessed
History of alcohol misuse Alcohol Use Disorders Identification
Test41; 2011–2013
Alcohol Use Disorders Identification Test41;
2015–2017
Questionnaire; 2006–2011
Current smokers (tobacco) Questionnaire; 2011–2013 Questionnaire; 2015–2017 Questionnaire; 2006–2011
Cognitive styles Negative Schemas Questionnaire42,
2011–2013
Cognitive Styles Questionnaire43; 2008–2010 Brief Resilience Scale44; 2015–2016
Difficulties accessing
mental health information
Not assessed Questionnaire; 2017–2018 Not assessed
Neuroticism Not assessed Big Five Factors of Personality –
Neuroticism45; 2005–2006
Eysenck Personality Questionnaire –
Neuroticism46; 2006–2011
Self-harm history Not assessed Questionnaire; 2015–2017 Linkage to lifetime medical records
Depression polygenic risk
score
Constructed from a recent GWAS on
depression47
Constructed from a recent GWAS on
depression47
Constructed from a recent GWAS on
depression47
Data are shown in format: measure used in analyses; timing of assessment. Questionnaire refers to a single questionnaire item used. ALSPAC-parents, original parents in the Avon Longitudinal
Study of Parents and Children; ALSPAC-young, original children in the Avon Longitudinal Study of Parents and Children; BMI, body mass index; GWAS, genome-wide association study.
a. We supplemented data with more recent timings of anxiety symptoms from the Clinical Interview Schedule – Revised between 2015 and 2017.
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To answer our second research objective (Are there groups
within the general population that are at heightened risk of depres-
sion and anxiety during the COVID-19 pandemic?), we examined
associations between factors measured before and during the
pandemic with depression and anxiety during the COVID-19 pan-
demic, accounting for pre-pandemic depression and anxiety (with
the most recent matchedmeasures available). We included pre-pan-
demic measures of depression and anxiety as covariates into our
regression models, so the shared variance between pre-pandemic
and COVD-19 pandemic depression and anxiety were accounted
for. The adjusted coefficients represent the extent to which the
factors are associated with depression and anxiety during the
COVID-19 pandemic, independent of prior mental health.
Analysis was conducted separately for all cohorts, adjusted for
sex, age and the date they completed the COVID-19 questionnaire
(to account for response times). We chose to run minimised
regressions to avoid potential biases from collider bias and to
identify risk populations who could be followed up in greater
detail, with more specific confounding structures. Pre-pandemic
mental well-being was not assessed in ALSPAC-parents or
Generation Scotland cohorts; therefore, we restricted this analysis
to depression and anxiety only. Continuous COVID-19 pandemic
and pre-pandemic depression and anxiety were standardised to
create Z-scores, allowing comparison of effect sizes across outcomes
and cohorts.
Missing data
Our eligible samples were those who completed at least one mental
health measure during the COVID-19 surveys: ALSPAC-parents
cohort, n = 3579; ALSPAC-young cohort, n = 2872 and Generation
Scotland cohort, n = 4208 (Supplement Figs 1–3, Supplement
Table 1). To address potential bias from attrition in the cohorts,
we imputed pre-pandemic depression, anxiety and factors, with
related information and auxiliary variables up to the eligible
samples, using multiple imputation by chained equations to gener-
ate 50 imputed data-sets.48 Details regarding imputation and a list of
auxiliary variables are available in the Supplementary Material.
Sensitivity analyses
We ran several sensitivity analyses, including complete-case ana-
lysis, adjusting for educational background with the imputed data,
using the validated cut-offs rather than continuous scores as out-
comes and using varying timings for pre-pandemic depression,
anxiety and financial problems, to ensure there were no substantial
changes as a result of proximal timings between assessments and the
COVID-19 pandemic. We also estimated ‘counterfactual’ trajector-
ies for the mental health measures in the ALSPAC-young cohort to
highlight differences in what would we expected had COVID-19 not
happened, given previous trajectories, compared with what was
observed during the pandemic. Finally, we analysed item-level
responses for the SMFQ, GAD-7 and SWEMWBS to examine
how specific components of each measurement differed from the
most recent pre-pandemic assessment and the COVID-19 pan-
demic assessment. Further information regarding these analyses
are given in the Supplementary Material.
Results
Data on mental health outcomes during the COVID-19 pandemic
were available for 3579 people (mean age 58.67 years, s.d. 4.82)
for the ALSPAC-parents cohort, 2872 people (mean age 27.61
years, s.d. 0.54) for the ALSPAC-young cohort and 4208 people
(mean age 59.24 years, s.d. 12.03) for the Generation Scotland
cohort. Individuals included in these analyses were more likely to
be female and have higher educational backgrounds, but did not
differ by pre-existing depression or anxiety symptoms (Supplementary
Table 1).
Prevalence of mental health outcomes during the
COVID-19 pandemic
The prevalence of probable depression during the COVID-19 pan-
demic was highest for younger individuals (ages 18–40 years), and
decreased with older age in ALSPAC and Generation Scotland.
Similar results were observed for probable anxiety and lower well-
being (Supplementary Figs 4 and 5).
Differences in mental health before and during the
COVID-19 pandemic in the ALSPAC-young cohort
The percentage of ALSPAC-young participants with probable
depression was lower during the pandemic, at 18.14% (95% CI
16.76–19.61%) compared with 24.35% (95% CI 23.04–26.70%) at
the most recent pre-pandemic assessment. However, the percentage
of participants with probable anxiety disorder almost doubled
during the pandemic, at 24.35% (95% CI 22.81–25.96%) compared
with pre-pandemic levels (12.97%, 95% CI 11.87–14.15%); as did
the percentage for lower well-being, at 13.27% (95% CI 12.07–
14.15%) compared with 7.59% (95% CI 6.82–8.43%) (Fig. 1,
Supplementary Tables 5 and 6). When examining continuous mea-
sures for comparisons between the most recent pre-pandemic and
pandemic assessments, there was a mean difference of −0.60 (95%
CI −0.84 to −0.37) in SMFQ score, 1.36 (95% CI 1.10–1.61) in
GAD-7 score and 2.45 (95% CI 2.25–2.65) in SWEMWBS score.
For magnitude, these estimates represent a 0.11, 0.26 and 0.51 stan-
dardised effect difference for depression, anxiety and lower well-
being, respectively (Supplementary Table 7). Item-level analysis
showed that for the SMFQ (depression), the only items that
scored higher during the COVID-19 pandemic were ‘no enjoy-
ment’, ‘felt restless’ and ‘found it hard to think’. For the GAD-7
(anxiety) and the SWEMWBS (mental well-being), all items
scored higher during the COVID-19 pandemic compared with
the most recent pre-pandemic assessment, with similar variances
(Supplementary Fig. 6).
Factors related to depression and anxiety during the
COVID-19 pandemic
Supplementary Table 8 and Figs 2 and 3 show all the associations
between pre-pandemic and COVID-19-specific factors and depres-
sion and anxiety during the early stages of COVID-19, accounting
for pre-pandemic assessments of depression and anxiety (measured
on a continuous scale in s.d. units for ease of comparison between
cohorts and outcomes, i.e. standardised regression coefficients).
As stated above, these results can be interpreted as factors associated
with depression and anxiety during the pandemic, after accounting
for previous depression and anxiety, thus resulting in associations
that are independent of prior mental health.
Pre-pandemic sociodemographic factors
Being female and pre-pandemic financial problems were associated
with higher depression and anxiety during the COVID-19 pan-
demic in ALSPAC-parents, ALSPAC-young and Generation
Scotland cohorts. Lower educational background was associated
with greater depression in ALSPAC-parents and Generation
Scotland cohorts, but not in the ALSPAC-young cohort; and with
greater anxiety in ALSPAC-parents and ALSPAC-young cohorts,
but not in the Generation Scotland cohort. Higher income before
the pandemic was associated with lower depression in ALSPAC-
Kwong et al
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parents and Generation Scotland cohorts, but not in the ALSPAC-
young cohort; and with lower anxiety in ALSPAC-young and
Generation Scotland cohorts, but not in the ALSPAC-parents
cohorts. Higher neighbourhood deprivation was associated with
higher depression in ALSPAC-parents and Generation Scotland
cohorts, but not in the ALSPAC-young cohort; and with higher
anxiety in ALSPAC-parents, ALSPAC-young and Generation
Scotland cohorts. Being a parent of a young child was associated
with higher anxiety in the ALSPAC-young cohort, but not in the
Generation Scotland cohort (not assessed in the ALSPAC-parents
cohort), and was not associated with depression in either cohort.
Reporting an emotionally abusive partner was only available in
the ALSPAC-parents cohort, and was positively associated with
both greater depression and anxiety. Estimates are given in
Supplementary Table 8 and shown in Figs 2A and 3A.
Physical health factors
Pre-pandemic obesity was associated with higher depression and
anxiety in all cohorts. Pre-pandemic asthma status had positive
associations with higher anxiety in ALSPAC-young and
Generation Scotland cohorts, but not in the ALSPAC-parents
cohort; and with higher depression in the Generation Scotland
cohort, but not in either ALSPAC cohorts (see Supplementary
Table 8 and Figs 2B and 3B).
COVID-19-specific factors
A self-reported suspected or confirmed COVID-19 diagnosis was
associated with higher depression and anxiety in the ALSPAC-
parents cohort, but only higher depression in Generation Scotland
and ALSPAC-young cohorts. Living alone during the pandemic
was also associated with higher depression in all cohorts, but was
not associated with anxiety. No access to a garden was associated
with higher depression in ALSPAC-parents, ALSPAC-young and
Generation Scotland cohorts, along with higher anxiety in the
Generation Scotland cohort. Self-isolation was associated with
higher depression and anxiety in both ALSPAC-parents and
ALSPAC-young cohorts, but was not measured in the Generation
Scotland cohort. Key workers (of any kind) and healthcare
workers were not associated with higher depression or anxiety in
any cohort. However, there was an association between being a
key worker and lower depression in the ALSPAC-young cohort,
but this was not replicated in the ALSPAC-parents or Generation
Scotland cohorts. Estimates are given in Supplementary Table 8





























































































Fig. 1 Changes in mental health from pre-pandemic to during the COVID-19 pandemic in the ALSPAC-young cohort. (a) Changes in probable
depression, as assessed by the SMFQ. (b) Changes in probable generalised anxiety disorder, as assessed by the GAD-7 at age 22 years and the
CISR GAD at ages 18 and 24 years. (c) Changes in lower well-being, as assessed by the SWEMWBS. ALSPAC-young, original children in the Avon
Longitduinal Study of Parents and Children; CISR GAD, Clinical Interview Schedule – Revised, Generalised Anxiety Disorder; GAD-7, Generalised
Anixety Disorder Assessment; SMFQ, Short Mood and Feelings Questionnaire; SWEMWBS, Short Warwick Edinburgh Mental Wellbeing Scale.
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Pre-pandemic mental health and psychological factors
There were consistent associations for factors such as a history of
major depression, a history of generalised anxiety disorder (not
assessed in Generation Scotland), negative cognitive styles, psych-
osis-like symptoms, higher neuroticism and a history of self-harm
(latter three not assessed in the ALSPAC-parents cohort). Eating
disorder traits were associated with higher depression and anxiety
in the ALSPAC-young cohort, but not in the ALSPAC-parents
cohort, and was not assessed in Generation Scotland. Personality
disorder traits were associated with greater depression in the
ALSPAC-parents cohort, but not in the ALSPAC-young cohort;
and with higher anxiety in both ALSPAC cohorts, but was not
assessed in Generation Scotland. The depression polygenic risk
score was positively associated with depression and anxiety in
ALSPAC-parents and Generation Scotland cohorts, but was not
associated with either depression or anxiety in the ALSPAC-
young cohort. A history of alcohol misuse was associated with
increased depression in the ALSPAC-young cohort, but not in
ALSPAC-parents or Generation Scotland cohorts; and with
increased anxiety in ALSPAC-parents and ALSPAC-young
cohorts, but not in the Generation Scotland cohort. By contrast,
daily smoking was associated with increased depression and
anxiety in ALSPAC-parents and Generation Scotland cohorts, but
not in the ALSPAC-young cohort. Several factors only measured
in the ALSPAC-young cohort showed strong associations with
higher depression and anxiety during the COVID-19 pandemic,
including high obsessive–compulsive traits, high autistic traits and
pre-pandemic reporting of difficulties accessing mental health ser-
vices (see Supplementary Table 8 and Figs 2C, 2D, 3C and 3D).
Sensitivity analyses
The main results were similar to the complete-case analysis
(Supplementary Table 9), adjusting for educational background
with the imputed sample (Supplementary Table 10); examining dif-
ferent pre-pandemic timings of depression, anxiety and factors
(Supplementary Tables 11–13); and examining the binary outcomes
of depression and anxiety (Supplementary Table 14). Trajectory
analyses (Supplementary Fig. 7) suggested higher anxiety and
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Fig. 2 Associations between pre-pandemic and COVID-19-specific factors and depression during the COVID-19 pandemic, adjusted for the most
recent pre-pandemic assessment of depression, sex, age and when the COVID-19 questionnaire was completed, using imputed data (estimates
match Supplementary Table 8). Estimates refer to an s.d. increase in depression, over and above pre-pandemic depression. (a) Associations
between pre-pandemic sociodemographic factors and depression during the COVID-19 pandemic. (b) Associations between pre-pandemic
physical health andCOVID-19-specific factors and depression during theCOVID-19 pandemic. (c and d) Associations betweenpre-pandemicmental
health factors and depression during the COVID-19 pandemic. ALSPAC-parents, original parents in the Avon Longitudinal Study of Parents and
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expected, given the previous trajectory of pre-pandemic assess-
ments. However, depression was in line with expectations.
Discussion
We report a population-based longitudinal study examining mental
health during the COVID-19 pandemic. Although we found no
clear evidence that depression differed during the COVID-19 pan-
demic from pre-pandemic assessments, there was strong observa-
tional evidence that anxiety was higher and well-being was lower
during the pandemic, compared with pre-pandemic levels.
Irrespective of the overall population differences in depression
and anxiety, several sociodemographic, psychological, physical
and COVID-19-specific factors were associated with greater depres-
sion and anxiety during the COVID-19 pandemic.
Mental health during the COVID-19 pandemic compared
with pre-pandemic assessments
Approximately twice as many young adults experienced probable
anxiety disorder and lower well-being during the pandemic,
compared with previous longitudinal assessments. The mean rises
of 0.26 s.d. in GAD-7 scores and 0.51 s.d. in SWEMWBS scores
represent effect sizes that are clinically important and of a magni-
tude similar to those seen following treatment.49,50 The rise in mag-
nitude of anxiety and reduction in well-being in the ALSPAC-young
cohort goes against expectations in the absence of COVID-19, high-
lighted in our sensitivity analysis with counterfactual trajectories,
and shown by the wealth of descriptive mental health data in
ALSPAC. The uncertainty and sudden change to everyday life, as
well as concerns over health, may explain why anxiety has initially
risen, rather than depression. The apparent rise in younger ages may
reflect the effects of mitigation measures (i.e. lockdown and social
distancing) rather than a risk of COVID-19 infection (potentially
higher in older populations). Furthermore, depression usually
relates to feelings of loss,51 whereas anxiety relates to threat,52
which in this case could be rapid change in society and potential
for adverse social and psychological outcomes. There is also evi-
dence that anxiety changes more rapidly than depression after treat-
ment.49 What separates this pandemic from historical outbreaks is
the global impact. This, alongside the community spirit, may have
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to depression.51 Indeed, the depression items that scored lower in
the pandemic, compared with pre-pandemic assessments, related
to feelings of self-blame. However, this may change as the pandemic
evolves and restrictions are eased, thus continued monitoring of
mental health is vital for understanding both the short- and long-
term impact of the pandemic.
Population factors associated with depression and
anxiety during the COVID-19 pandemic
When accounting for pre-pandemic depression and anxiety, a
reported or suspected COVID-19 infection was a factor for higher
depression and anxiety during the pandemic in ALSPAC-parents
and Generation Scotland cohorts, possibly reflecting the high per-
ceived risk to physical health in older ages and supporting previous
research,2 but must be interpreted with some caution because
COVID-19 status in this study largely includes participants’ percep-
tion that they have COVID-19 (because of a lack of testing at this
stage of the pandemic). It may be that those with pre-existing
depression and anxiety are also more likely to perceive that their
symptoms are COVID-19-related, and are therefore subject to
reverse causation. There was consistent evidence from participants
in ALSPAC and Generation Scotland that health risk groups previ-
ously associated with COVID-19, such as those with pre-pandemic
obesity and, to some extent, pre-pandemic asthma, had higher
depression and anxiety during the pandemic, potentially reflecting
concerns regarding perceived risk of infection or the effects of
more stringent social distancing. There was no evidence that key
workers or health workers were at greater risk of depression or
anxiety, suggesting that these groups are not yet experiencing
difficulties.
Those who were self-isolating were at higher risk of both anxiety
and depression, but living alone was consistently associated with
greater depression only. The manifestation of depression rather
than anxiety for those living alone may relate to loneliness, which
is amplified with physical contact restricted to within households,
again reflecting depression being related to absence and loss
rather than threat, whereas self-isolation (which in this context is
related to COVID-19 exposure) may be linked to anxiety through
associated threat of the virus. Parents of young children were
more anxious in ALSPAC, which may reflect stress related to the
sudden change in child care provision. Financial problems, lower
income and deprivation were associated with greater risk of depres-
sion and anxiety in ALSPAC-parents and Generation Scotland
cohorts. Financial problems were also associated with higher
depression and anxiety in the ALSPAC-young cohort. Although
these cohorts may have different populations, the replication of
financial concerns highlights the importance of global policies to
mitigate the sudden socioeconomic impact of the pandemic. and
ensure financial measures are accessible to those in need.53
As expected, individuals with a history of worse mental health
across multiple domains were at greater risk of higher depression
and anxiety during the pandemic, supporting concerns raised at
the beginning of this pandemic1,15,54,55 and highlighting groups
who could benefit from immediate support. Personality traits
such as neuroticism and negative thinking patterns were strong
factors for higher depression and anxiety during the pandemic,
and are modifiable with interventions that could benefit those at
risk currently or in future outbreaks, even if delivered remotely.56
However, there are several limitations. First, as the pandemic is
a universal exposure, it is difficult to attribute COVID-19 or its
management directly to mental health outcomes. Many factors
are likely to show an association with later depression and anxiety
at any time.51 However, we were able to use rich longitudinal data
and methods before and during the COVID-19 pandemic, to
demonstrate that anxiety and lower well-being were worse during
the pandemic compared with several recent occasions. Sensitivity
analysis suggested that this may go against expectations, but detailed
follow-up of these measures is essential to fully understand the tra-
jectory of mental health as a result of the COVID-19 pandemic.
Nevertheless, it is likely these effects are, to some extent, related
to COVID-19, and these results are some of the first to highlight
observational associations that could be tested in more causal set-
tings in future. Second, there were some differences in the measures
used to assess mental health, both in the pre-pandemic and COVID-
19 surveys and across cohorts. The ALSPAC-young cohort was the
only cohort that had the same measures of mental health before and
during the pandemic, meaning we were only able to accurately
describe the change in mental health in this cohort. Thus, the sub-
stantial increase in anxiety and decrease in well-being may only be
relevant to young populations. Caution must be taken when com-
paring change over time in the ALSPAC-parents cohort analysis
because the measures differed before and during the pandemic.
However, our analysis exploring the relationship between factors
and mental health during the COVID-19 pandemic remains valid,
as despite different pre-pandemic and COVID-19 pandemic mea-
sures, the underlying constructs of the measures are the same.
These measures were validated against the same standard interview
measures, meaning that it is possible to compare longitudinal asso-
ciations across cohorts, a major strength of our study compared
with some previous cross-sectional research. A third limitation is
the difference in follow-up length across cohorts. These can be
subject to recency effects, where results are stronger if they were
measured more proximal to the outcome. However, sensitivity ana-
lyses exploring different pre-pandemic timings for depression and
anxiety as mental health covariates, and for financial problems as
a factor, gave similar conclusions, as shown in Supplementary
Tables 11–13. Furthermore, under usual circumstances, depression
and anxiety in adulthood are relatively stable, with measures several
years apart showing high correlations.57,58 Thus, even measures
assessed a number of years ago are valid methods to account for pre-
vious mental health. Finally, although we were able to use existing
data such as educational background to identify pre-pandemic
missingness and use such variables in imputation models, we did
not impute any data beyond the sample with complete COVID-
19 survey data, given that the data were unique. Thus, there may
be issues with generalisability, as respondents were more likely to
be female and from higher educational backgrounds than previous
surveys.
In conclusion, these results are some of the first to provide an
initial indication that the COVID-19 pandemic and related mitiga-
tion measures are associated with a clinically relevant increase in
anxiety in younger populations. Several groups within the popula-
tion were at heightened risk of higher levels of depression and
anxiety during the pandemic. Future work is needed to understand
the mechanisms and interplay between pre-pandemic and COVID-
19-specific factors and mental health during the COVID-19 pan-
demic. Future research should consider how changes in anxiety
might influence public behaviour through contact patterns and
adherence to policies. Depression and anxiety, along with associated
impairment, should continue to be carefully monitored to forecast
the long-term impact of this crisis. This can help to ensure that
future policies consider optimal preservation of both physical and
mental health.
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